Novel ghrelin inverse agonist as therapeutic candidate against obesity-related metabolic diseases Jan. 25, 2019
PROLONG study of OBE-022 in preterm labor advances into part B following successful part A Jan. 23, 2019
FDA accepts IND application for phase I/II study of AVR-RD-04 gene therapy for cystinosis Jan. 21, 2019
Top-line data presented from phase II study of NYX-2925 in painful diabetic peripheral neuropathy Jan. 17, 2019
RSS